Logo image of ENVIP.OL

ENVIPCO HOLDING NV (ENVIP.OL) Stock Fundamental Analysis

OSL:ENVIP - Euronext Oslo - NL0015000GX8 - Common Stock - Currency: NOK

65.8  +2.2 (+3.46%)

Fundamental Rating

4

ENVIP gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 106 industry peers in the Machinery industry. While ENVIP seems to be doing ok healthwise, there are quite some concerns on its profitability. ENVIP is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ENVIP has reported negative net income.
In the past year ENVIP had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ENVIP reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: ENVIP reported negative operating cash flow in multiple years.
ENVIP.OL Yearly Net Income VS EBIT VS OCF VS FCFENVIP.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

ENVIP has a worse Return On Assets (-0.50%) than 69.81% of its industry peers.
The Return On Equity of ENVIP (-0.95%) is worse than 67.92% of its industry peers.
ENVIP has a Return On Invested Capital (4.17%) which is in line with its industry peers.
Industry RankSector Rank
ROA -0.5%
ROE -0.95%
ROIC 4.17%
ROA(3y)-1.73%
ROA(5y)-1.7%
ROE(3y)-4.84%
ROE(5y)-4.16%
ROIC(3y)N/A
ROIC(5y)N/A
ENVIP.OL Yearly ROA, ROE, ROICENVIP.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

ENVIP's Operating Margin of 3.86% is on the low side compared to the rest of the industry. ENVIP is outperformed by 64.15% of its industry peers.
The Gross Margin of ENVIP (36.57%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ENVIP has remained more or less at the same level.
Industry RankSector Rank
OM 3.86%
PM (TTM) N/A
GM 36.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.6%
GM growth 5Y-0.44%
ENVIP.OL Yearly Profit, Operating, Gross MarginsENVIP.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

5

2. Health

2.1 Basic Checks

ENVIP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ENVIP has more shares outstanding
ENVIP has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ENVIP has been reduced compared to a year ago.
ENVIP.OL Yearly Shares OutstandingENVIP.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ENVIP.OL Yearly Total Debt VS Total AssetsENVIP.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 4.04 indicates that ENVIP is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 4.04, ENVIP belongs to the best of the industry, outperforming 88.68% of the companies in the same industry.
A Debt/Equity ratio of 0.14 indicates that ENVIP is not too dependend on debt financing.
ENVIP's Debt to Equity ratio of 0.14 is amongst the best of the industry. ENVIP outperforms 82.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z 4.04
ROIC/WACC0.57
WACC7.34%
ENVIP.OL Yearly LT Debt VS Equity VS FCFENVIP.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

ENVIP has a Current Ratio of 1.97. This is a normal value and indicates that ENVIP is financially healthy and should not expect problems in meeting its short term obligations.
ENVIP's Current ratio of 1.97 is fine compared to the rest of the industry. ENVIP outperforms 71.70% of its industry peers.
A Quick Ratio of 1.34 indicates that ENVIP should not have too much problems paying its short term obligations.
ENVIP has a better Quick ratio (1.34) than 73.58% of its industry peers.
Industry RankSector Rank
Current Ratio 1.97
Quick Ratio 1.34
ENVIP.OL Yearly Current Assets VS Current LiabilitesENVIP.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

7

3. Growth

3.1 Past

The earnings per share for ENVIP have decreased strongly by -177.86% in the last year.
The Revenue has grown by 34.51% in the past year. This is a very strong growth!
ENVIP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.59% yearly.
EPS 1Y (TTM)-177.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-87.5%
Revenue 1Y (TTM)34.51%
Revenue growth 3Y45.27%
Revenue growth 5Y26.59%
Sales Q2Q%2.67%

3.2 Future

ENVIP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 379.32% yearly.
The Revenue is expected to grow by 50.92% on average over the next years. This is a very strong growth
EPS Next Y1528%
EPS Next 2Y634.98%
EPS Next 3Y379.32%
EPS Next 5YN/A
Revenue Next Year32.37%
Revenue Next 2Y43.56%
Revenue Next 3Y50.92%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ENVIP.OL Yearly Revenue VS EstimatesENVIP.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
ENVIP.OL Yearly EPS VS EstimatesENVIP.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2019 2022 2023 2024 2025 2026 2027 0 0.2 0.4 0.6 0.8 1

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ENVIP. In the last year negative earnings were reported.
ENVIP is valuated quite expensively with a Price/Forward Earnings ratio of 39.02.
ENVIP's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. ENVIP is more expensive than 70.75% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.86. ENVIP is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 39.02
ENVIP.OL Price Earnings VS Forward Price EarningsENVIP.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300 -400 -500

4.2 Price Multiples

74.53% of the companies in the same industry are cheaper than ENVIP, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 23.85
ENVIP.OL Per share dataENVIP.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ENVIP's earnings are expected to grow with 379.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y634.98%
EPS Next 3Y379.32%

0

5. Dividend

5.1 Amount

ENVIP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ENVIPCO HOLDING NV

OSL:ENVIP (5/2/2025, 7:00:00 PM)

65.8

+2.2 (+3.46%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)03-20 2025-03-20/bmo
Earnings (Next)N/A N/A
Inst Owners27.13%
Inst Owner ChangeN/A
Ins Owners35.17%
Ins Owner ChangeN/A
Market Cap3.80B
Analysts85.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-112.25%
Min EPS beat(2)-149.02%
Max EPS beat(2)-75.49%
EPS beat(4)0
Avg EPS beat(4)-118.38%
Min EPS beat(4)-149.02%
Max EPS beat(4)-75.49%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.49%
Min Revenue beat(2)-10.46%
Max Revenue beat(2)7.48%
Revenue beat(4)1
Avg Revenue beat(4)-4.65%
Min Revenue beat(4)-11.7%
Max Revenue beat(4)7.48%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-57.58%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.56%
Revenue NY rev (3m)-3.56%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 39.02
P/S 2.73
P/FCF N/A
P/OCF 263.7
P/B 4.76
P/tB 6.11
EV/EBITDA 23.85
EPS(TTM)-0.12
EYN/A
EPS(NY)1.69
Fwd EY2.56%
FCF(TTM)-1.09
FCFYN/A
OCF(TTM)0.25
OCFY0.38%
SpS24.12
BVpS13.82
TBVpS10.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.5%
ROE -0.95%
ROCE 5.42%
ROIC 4.17%
ROICexc 6.58%
ROICexgc 9.15%
OM 3.86%
PM (TTM) N/A
GM 36.57%
FCFM N/A
ROA(3y)-1.73%
ROA(5y)-1.7%
ROE(3y)-4.84%
ROE(5y)-4.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.6%
GM growth 5Y-0.44%
F-Score6
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA 0.73
Cap/Depr 79.46%
Cap/Sales 5.54%
Interest Coverage 250
Cash Conversion 9.55%
Profit Quality N/A
Current Ratio 1.97
Quick Ratio 1.34
Altman-Z 4.04
F-Score6
WACC7.34%
ROIC/WACC0.57
Cap/Depr(3y)125.69%
Cap/Depr(5y)118.36%
Cap/Sales(3y)9.77%
Cap/Sales(5y)10.64%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-177.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-87.5%
EPS Next Y1528%
EPS Next 2Y634.98%
EPS Next 3Y379.32%
EPS Next 5YN/A
Revenue 1Y (TTM)34.51%
Revenue growth 3Y45.27%
Revenue growth 5Y26.59%
Sales Q2Q%2.67%
Revenue Next Year32.37%
Revenue Next 2Y43.56%
Revenue Next 3Y50.92%
Revenue Next 5YN/A
EBIT growth 1Y99.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year446.67%
EBIT Next 3Y176.48%
EBIT Next 5YN/A
FCF growth 1Y-6.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-56.14%
OCF growth 3Y34.86%
OCF growth 5Y8.65%